|
SFPQ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.999840E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.961200E-01 |
| Normal-vs-Stage2 |
6.163400E-01 |
| Normal-vs-Stage3 |
3.652300E-02 |
| Normal-vs-Stage4 |
3.142400E-01 |
| Stage1-vs-Stage2 |
8.218800E-01 |
| Stage1-vs-Stage3 |
1.359400E-01 |
| Stage1-vs-Stage4 |
8.794000E-01 |
| Stage2-vs-Stage3 |
2.214600E-01 |
| Stage2-vs-Stage4 |
7.550600E-01 |
| Stage3-vs-Stage4 |
2.758200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.596000E-02 |
| Normal-vs-AfricanAmerican |
6.026000E-01 |
| Normal-vs-Asian |
1.634590E-01 |
| Caucasian-vs-AfricanAmerican |
3.105600E-02 |
| Caucasian-vs-Asian |
3.560100E-03 |
| AfricanAmerican-vs-Asian |
9.578200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.535700E-02 |
| Normal-vs-Female |
7.032600E-01 |
| Male-vs-Female |
3.835100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.338200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.457600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.635180E-01 |
| Normal-vs-Age(81-100Yrs) |
1.052210E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.765400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.200000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.813000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.801400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.751600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.858400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.733640E-01 |
| Normal-vs-Grade 2 |
7.561600E-01 |
| Normal-vs-Grade 3 |
2.567800E-02 |
| Normal-vs-Grade 4 |
7.450400E-02 |
| Grade 1-vs-Grade 2 |
3.995900E-02 |
| Grade 1-vs-Grade 3 |
4.633800E-02 |
| Grade 1-vs-Grade 4 |
5.265600E-02 |
| Grade 2-vs-Grade 3 |
1.166490E-02 |
| Grade 2-vs-Grade 4 |
9.670400E-02 |
| Grade 3-vs-Grade 4 |
8.869800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.700600E-01 |
| Normal-vs-ccB subtype |
1.277930E-03 |
| ccA subtype-vs-ccB subtype |
3.99780000004402E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.192100E-02 |
| Normal-vs-N1 |
3.329400E-01 |
| N0-vs-N1 |
9.312800E-01 |
|
|
